Xiaolin Liu

机构：Sun Yat-sen University, Eighth Affiliated Hospital of Sun Yat-sen University · ORCID：0009-0000-4824-8820

发表论文 26 篇 · 总被引 534 次 · h-index 14

代表论文

• Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction (2016 · Experimental Cell Research · 被引 99)
• How does ChatGPT-4 preform on non-English national medical licensing examination? An evaluation in Chinese language (2023 · PLOS Digital Health · 被引 78)
• Performance of ChatGPT on the Chinese Postgraduate Examination for Clinical Medicine: Survey Study (2023 · JMIR Medical Education · 被引 37)
• A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease (2024 · Hepatology International · 被引 33)
• MA11.06 A PII Study of Toripalimab, a PD-1 mAb, in Combination with Chemotherapy in EGFR+ Advanced NSCLC Patients Failed to Prior EGFR TKI Therapies (2019 · Journal of Thoracic Oncology · 被引 32)
• Traditional Chinese medication Tongxinluo attenuates apoptosis in ox-LDL-stimulated macrophages by enhancing Beclin-1-induced autophagy (2018 · Biochemical and Biophysical Research Communications · 被引 31)